Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acacetin-incorporated lipid nanoparticles for inhaled mRNA vaccines.

Nanoscale horizons·2026
Same author

Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

β-Hydroxy Thioether-Derived Ionizable Lipids for Spleen-Tropic mRNA Delivery and <i>In Vivo</i> Chimeric Antigen Receptor T Cell Engineering.

ACS nano·2026
Same author

Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy.

Nature nanotechnology·2026
Same author

Crosslinked ionizable lipids reprogram dendritic cell metabolism for potent mRNA vaccination.

Nature materials·2026
Same author

Time-ordered-expression mRNA (TOE mRNA) for melanoma RNA vaccines.

Chemical science·2026

Related Experiment Video

Updated: Jan 18, 2026

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

6.5K

Nanomaterials Application for STING Pathway-Based Tumor Immunotherapy.

Wenrui Zhao1,2, Xiaolin Tang2, Yucui Qin2

  • 1Department of Infectious Diseases, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China.

International Journal of Nanomedicine
|September 10, 2025
PubMed
Summary

Nanomaterials enhance STING pathway activation for tumor immunotherapy by improving delivery and reducing toxicity. This approach shows promise for more effective cancer vaccines and treatments.

Keywords:
STING agonistSTING pathwaynanomaterialtumor immunotherapy

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.4K

Related Experiment Videos

Last Updated: Jan 18, 2026

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

6.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.4K

Area of Science:

  • Immunology
  • Nanotechnology
  • Oncology

Background:

  • The STING pathway is crucial for anti-tumor immunity, inducing interferon responses and T cell activation.
  • Current STING pathway-based tumor immunotherapy faces challenges like poor delivery, rapid agonist degradation, and systemic toxicity.

Purpose of the Study:

  • To review the application of nanomaterials in STING pathway-based tumor immunotherapy.
  • To explore strategies for enhancing tumor vaccines, modulating the tumor microenvironment, and improving T cell therapies using nanotechnology.

Main Methods:

  • Systematic review of nanomaterial applications in STING pathway-based tumor immunotherapy.
  • Focus on strategies including enhanced vaccine efficacy, tumor microenvironment modulation, and T cell-mediated immunotherapy.

Main Results:

  • Nanotechnology offers solutions for targeted delivery, sustained STING activation, and improved immune presentation.
  • Nanomaterials can enhance tumor vaccine efficacy, modulate the tumor microenvironment, and boost T cell-mediated anti-tumor responses.

Conclusions:

  • STING pathway-based nanomaterials present a promising strategy for overcoming limitations in current tumor immunotherapy.
  • Further research and clinical translation are needed, considering regulatory hurdles and biosafety.